HISTOPLASMOSIS

A disease caused by the fungus Histoplasma capsulatum

Entry to Body ENTRY TO THE BODY
Histoplasma spores produced by the organism are inhaled into the body
Spores settle in the lungs and cause disease which affects the lungs

Clinical Features CLINICAL FEATURES

many manifestations :

Often no apparent effects, often going unnoticed.
The severest symptoms occur in those individuals already suffering from lung complications

common cases - possibly no symptoms
influenza-like illness, fever, headache, cough, myalgia,

acute benign respiratory disease - possibly no symptoms
spores enter the lungs general ill feeling, chest pain, dry cough,
many acute cases resolve themselves

chronic- often following acute disease
resembles tuberculosis, can worsen over months or years
almost exclusively occurs in those with lung dysfunction
lung destruction and loss of function common

disseminated - fatal unless treated.
cells disseminate to organs of the body via lymphatics
average length before symptoms is 10 days after exposure
common in cancer and AIDS patients.
similar to septic shock in HIV-infected persons.
chronic cases lead to lung damage

Histoplasmosis dissemination
Image copyright (c) www.doctorfungus.org and used by permission
Histoplasmosis dissemination to skin
Image copyright (c) www.doctorfungus.org and used by permission
Transmission

TRANSMISSION
Disease cannot be transmitted from infected person to another.

Risk groups RISK GROUPS
infants/young children, over 50s
chronic lung disease at risk for severe disease.
construction, agricultural workers,
immunocompromised, cancer, HIV, transplant patients.
steroid and immunosuppressant drug users
Those in endemic areas exposed to bird/bat droppings
agricultural workers, construction workers

Incidence and Global Distribution INCIDENCE AND GLOBAL DISTRIBUTION
United States, particularly in the river valleys
More than 80 percent of people in these areas have been infected at one or another time by this fungus
Some parts of Asia and Europe
10% mortality in HIV disseminated infected persons
10% - 25% OF HIV infected people in endemic areas develop disseminated histoplasmosis..

Diagnosis DIAGNOSIS
Skin tests show exposure to organism
Blood, bone marrow, lymph nodes, sputum, skin, liver or lung

Specimens can be cultured for the fungus
Blood tests to reveal antibodies to the fungus

Treatment and Prevention TREATMENT AND PREVENTION
Mild disease usually doesn't need treatment
Amphotericin B via IV to treat serious cases
AIDS patients require lifelong treatment due to high chances of relapse
Past infection results in partial immunity
Precaution - avoid areas infected with the fungus
If working - wear disposable clothing and facemask
Formalin in solution sprayed into the air will kill the spores.
Organisms causing Histoplasmosis
Back to Systemic Mycoses

Main Mycoses Menu